The report titled “APAC
Healthcare AI Market Outlook to 2025 – By Applications (Machine/Robot Assisted
Medical Procedures, Clinical Trial & Drug Discovery/Development,
Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing
Assistant, Fraud Detection, Dosage Error Reduction), by Countries, by End Users
& by Technologies and Current Investment Scenario” covers market size by revenue generated by
Artificial Intelligence providers in Healthcare Market in Asia Pacific region
along with market segmentation by Technology (Deep Learning Method, Querying
Method, Natural Language Processing and Context Aware Processing), by
Application (Machine/Robot Assisted Medical Procedures, Clinical Trial &
Drug Discovery/Development, Preliminary Diagnosis, Administrative Workflow
Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction
and Others), by End User (Hospitals/Clinics/Healthcare Providers, Medical
Devices Companies, Pharmaceuticals & Biotechnology Companies and Others
Including Payers and Other Software Providers) and by Country (Japan, China,
Australia, India, Singapore and Rest of APAC) for the period 2013-2025. The
report also covers emerging growth drivers and trends; innovation, adoption and
application gap in comparison to US and Europe; case studies on various
healthcare application areas and competitive landscape of players in the market
with special focus on IBM, NVIDIA Corporation, Intel, Microsoft Corporation,
iCarbonX, Alphabet Inc., Next IT Verint Corporation, Welltok Incorporation,
Oncora Medical, Entilic Incorporation, Koninklijke Philips and General
Vision. The interpretation explores
investment trends in the market, major funding opportunities by stage,
potential markets of investment activity along with future outlook &
projections highlighting the major opportunities & cautions to the reader.
This report will particularly help the readers to identify the ongoing trends
in the industry and anticipated growth in the future depending upon changing
industry dynamics in upcoming years.
APAC AI in Healthcare Market Summary
Market Overview: APAC AI in Healthcare Market
has witnessed strong growth owing to rising number of collaborations,
investments and partnerships among hospitals, healthcare providers, AI
developers and medical device manufacturers; improved accuracy and predictive
capacity of AI powered devices, limited number of skilled healthcare
professionals in developing countries such as China and India and over the
years advancements in processor design and manufacturing techniques across Asia
Pacific region. The market size by revenue witnessed a five year CAGR of close
to 56% during the review period (2013-2018) due to the combined effect of these
factors. The market is currently placed in high growth stage with strong
possibility for further innovations and developments at a faster pace with
positive trends expected in the industry.
Market Segmentations
By Technology (Deep Learning, Querying
Method, Natural Language Processing and Context Aware Processing)
APAC AI in Healthcare Market incorporates
various technologies such as Deep Learning Method, Natural Language Processing
and Context Aware Processing. In 2018, majority of the revenue was contributed
by Natural Language Processing method owing to its high application in health
robots, hospital management systems and decision making services. This was
followed by Querying Method which contributed second highest share to the total
revenue in 2018. The remaining share was contributed by Context Aware
Processing and Deep Learning Method.
By Application (Machine/Robot Assisted
Medical Procedures, Clinical Trial & Drug Discovery/Development,
Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing
Assistant, Fraud Detection, Dosage Error Reduction and Others)
APAC AI in Healthcare Market application areas
include Machine/Robot Assisted Medical Procedures, Clinical Trial & Drug
Discovery/Development, Preliminary Diagnosis, Administrative Workflow
Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction
and Others (including Fitness & Wellness Tech Devices). In 2018, highest
contribution to overall revenue was made by machine/robot assisted medical
procedures owing to high robot costs and limited technical capabilities in Asia
Pacific region. Second highest contribution to revenue was made by clinical trial
& drug discovery/development and preliminary diagnosis owing to its
application in multiple fields. This was followed by administrative workflow
assistance, virtual nursing assistant, fraud detection, dosage error reduction
and others (including Fitness & Wellness Tech (Physical Fitness, Mind &
Body Wellness).
By End Users
(Hospitals/Clinics/Healthcare Providers, Medical Devices Companies,
Pharmaceuticals & Biotechnology Companies and Others Including Payers and
Other Software Providers)
APAC AI in Healthcare majorly includes four
categories of end users including Hospitals/Clinics/Healthcare Providers,
Medical Devices Manufacturers or Companies, Pharmaceuticals & Biotechnology
Companies and Others, including Payers and Other Software Providers. In 2018,
highest proportion of revenue was contributed by Hospitals/Clinics/Healthcare
Providers. Factors driving demand in Hospitals and healthcare centers includes
high application of AI in overall management of hospitals through usage of
several healthcare management software, high adoption of AI in medical devices
and machineries used in hospitals, AI being used for mundane tasks in order to
reduce workload of doctors, nurses and others. Medical device manufacturers
were seen to be the second highest contributor to revenue in 2018. This was
followed by Pharmaceuticals & Biotechnology Companies and Others Including
Payers and Other Software Providers.
By Country (Japan, China, Australia,
India, Singapore and Rest of APAC)
In global scenario, Asia Pacific region is one
of the fastest growing regions with presence of leading companies such as IBM,
Microsoft, Google and others. In terms of technological developments and
innovations, Japan and China are seen to be fastest growing nations in Asia
Pacific region. In 2018, Japan contributed highest revenue to the overall
revenue generated in AI healthcare market in Asia Pacific region followed by
China with very low difference. Other APAC countries such as Thailand and
Malaysia were noted to be the third largest revenue contributors in the region
owing to factors such as high AI adoption rate in these countries. This was
followed by Australia, India and Singapore.
Competitive Landscape in APAC AI in
Healthcare Market:
The nature of APAC AI in Healthcare Market differs on the basis of the number
of players and share in overall revenue generation. When analyzing on the basis
of number of players, the market is considered to be fragmented with high
number of small and large players present in the market though only few big players
occupy the highest revenue share. These include companies such as IBM,
Microsoft, iCarbonX, Alphabet Inc. and others. The major competing parameters
in the market include ease of AI integration in current systems and devices,
customization services offered in AI application software, accessibility and
number of patents earned.
APAC AI in Healthcare Market Future
Outlook and Projections:
Over the forecast period 2019-2025, APAC AI Healthcare Market is predicted to
grow at a CAGR of close to 54% in terms of revenue. Major growth in coming
years will be supported by factors such as supportive legislative regulations,
high investments by new startups and already established companies looking for
expansion, innovations and developments for new products and others.
Key Segments Covered in APAC AI in
Healthcare Market
By Technology (On the basis of
Revenue)
Deep Learning Method
Querying Method
Natural Language Processing
Context Aware Processing
By Application (On the basis of
Revenue)
Machine/Robot Assisted Medical Procedures
Clinical Trial & Drug
Discovery/Development
Preliminary Diagnosis
Administrative Workflow Assistance
Virtual Nursing Assistant
Fraud Detection
Dosage Error Reduction
Others (including Fitness & Wellness Tech
(Physical Fitness, Mind & Body Wellness)
By End Users (On the basis of Revenue)
Hospitals/Clinics/Healthcare Providers
Medical Devices Companies
Pharmaceuticals & Biotechnology Companies
Others Including Payers and Other Software
Providers
By Country (On the basis of Revenue)
Japan
China
Australia
India
Singapore
Rest of APAC
Key Target Audience
Hospitals, Clinics and Healthcare Providers
Medical Device Manufacturers
Insurance Providers
AI Developers
Healthcare Software Providers
Pharmaceuticals & Biotechnology Companies
Research Institutes
Venture Capital Firms
Time Period Captured in the Report:
Historical Period – 2013-2018
Forecast Period – 2019-2025
Companies Covered:
IBM
NVIDIA Corporation
Intel
Microsoft Corporation
iCarbonX
Alphabet Inc.
Next IT Verint Corporation
Welltok Incorporation
Oncora Medical
Entilic Incorporation
Koninklijke Philips
General Vision
Key Topics Covered in the Report
APAC AI in Healthcare Value Chain &
Ecosystem
APAC AI in Healthcare Market Size Analysis,
2013– 2018
APAC Healthcare AI Market Segmentation,
2013-2025E
Innovation, Adoption and Application Gap -
Comparison of APAC with Europe & US
Regulatory Framework in APAC AI in Healthcare
Market
Case Studies on Various Application Areas of
AI in Healthcare, 2013-2018
Competitive Landscape in APAC AI in Healthcare
Market, 2018
Company Profiling Of Major Players Operating
in APAC Artificial Intelligence in Healthcare Market
Investment Scenario- Healthcare in AI, 2018
Taxonomy
Markets of Investment Activity
Future Market Sizing Analysis, 2019E-2025E
For more information, refer to below
link:
Related Reports
No comments:
Post a Comment